United States · FDA National Drug Code directory

Omeprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68462-397_69b1e229-f845-4608-be48-f97e8d3e2273
Product NDC
68462-397
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Omeprazole
Labeler
Glenmark Pharmaceuticals Inc., USA
Marketing category
ANDA
Marketing start / end (source format)
20141031
Source listing expiry
20271231

Source-listed ingredients

  • OMEPRAZOLE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68462-397-01) · 68462-397-01
  • 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68462-397-10) · 68462-397-10
  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68462-397-30) · 68462-397-30
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68462-397-90) · 68462-397-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →